ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
An inhibitory ligand acts directly on CD3e to regulate T cell activation, and disruption of the interaction boosts tumor-specific T cell cytotoxicity to limit tumor growth.